Show simple item record

Differences in Healthcare Utilization and Associated Costs Between Patients Prescribed vs. Nonprescribed Opioids During an Inpatient or Emergency Department Visit

dc.contributor.authorXie, Linen_US
dc.contributor.authorJoshi, Ashish V.en_US
dc.contributor.authorSchaaf, Daviden_US
dc.contributor.authorMardekian, Jacken_US
dc.contributor.authorHarnett, Jamesen_US
dc.contributor.authorShah, Nilay D.en_US
dc.contributor.authorBaser, Onuren_US
dc.date.accessioned2014-06-04T14:57:06Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-06-04T14:57:06Z
dc.date.issued2014-06en_US
dc.identifier.citationXie, Lin; Joshi, Ashish V.; Schaaf, David; Mardekian, Jack; Harnett, James; Shah, Nilay D.; Baser, Onur (2014). "Differences in Healthcare Utilization and Associated Costs Between Patients Prescribed vs. Nonprescribed Opioids During an Inpatient or Emergency Department Visit." Pain Practice 14(5): 446-456.en_US
dc.identifier.issn1530-7085en_US
dc.identifier.issn1533-2500en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/107375
dc.description.abstractObjectives Compare healthcare resource utilization ( HCRU ) and costs between patients prescribed opioids ( R x OP ) and those who were not ( N o R x OP ) during an emergency department ( ED ) or inpatient visit. Methods Retrospective cohort analysis was performed ( J anuary 2006 to S eptember 2010). Continuously eligible R x OP patients in ED /inpatient settings ( J anuary 2007 to S eptember 2009) were included if age was ≥ 12 years by initial prescription date (or random date between first ED /inpatient admission and S eptember 30, 2009 [ N oRx OP patients]). Healthcare resource utilization and costs for 12 months after initial prescription were compared. Univariate descriptive analyses were performed for baseline and outcome variables and compared using appropriate tests. Risk adjustment compared HCRU between R x OP and N o R x OP cohorts for the postindex period. Results Of 27,599 eligible patients, R x OP patients ( n  = 18,819) were younger, less likely to be male, more likely to reside in southern U nited S tates and to have Preferred Provider Organization health plans, and had lower comorbidity index scores, compared with N o R x OP patients ( n  = 8,780). R x OP patients were less likely to have nonpain‐related comorbidities and more frequently diagnosed with pain‐related comorbidities. Unmatched and propensity‐matched R x OP patients experienced higher HCRU and costs in all subcategories (total, inpatient, outpatient ED , physician, pharmacy, other outpatient settings). Opioid abuse frequency was low in patients with common diagnoses/procedures within 3 months before initial prescription (0.48%). Average time to abuse was < 1 year (201 days). Conclusion Most patients were prescribed opioids initially during ED /inpatient visits and incurred higher HCRU than those not prescribed opioids. Among those with diagnosed opioid abuse after initiating opioids, time to diagnosis was rapid (range: 14 to 260 days) for patients with common diseases and procedures.en_US
dc.publisherSubstance Abuse and Mental Health Services Administrationen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherOpioid‐Related Disordersen_US
dc.subject.otherHealthcare Costsen_US
dc.subject.otherHealthcare Utilizationen_US
dc.subject.otherOpioid Abuseen_US
dc.subject.otherOpioidsen_US
dc.titleDifferences in Healthcare Utilization and Associated Costs Between Patients Prescribed vs. Nonprescribed Opioids During an Inpatient or Emergency Department Visiten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/107375/1/papr12098.pdf
dc.identifier.doi10.1111/papr.12098en_US
dc.identifier.sourcePain Practiceen_US
dc.identifier.citedreferenceThe Joint Commission, Sentinel Event Alert. Safe Use of Opioids in Hospitals. 49; 2012. http://www.jointcommission.org/assets/1/18/SEA_49_opioids_8_2_12_final.pdf (accessed October 8, 2012).en_US
dc.identifier.citedreferenceBell K, Salmon A. Pain, physical dependence, and pseudo‐addiction: redefining addiction for “nice” people. Int J Drug Policy. 2009; 20: 170 – 178.en_US
dc.identifier.citedreferenceKuehn BM. Opioid prescriptions soar. JAMA. 2007; 297: 249 – 251.en_US
dc.identifier.citedreferenceCompton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006; 81: 103 – 107.en_US
dc.identifier.citedreferenceSubstance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings (Office of Applied Studies, NSDUH Series H‐38A, HHS Publication No. SMA 10‐4856). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2010.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Morbidity and Mortality Weekly Report. CDC Grant Rounds: Prescription Drug Overdoses—A U.S. Epidemic; 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm (accessed November 12, 2012).en_US
dc.identifier.citedreferenceDepartment of Justice. Drug Enforcement Administration. Office of Diversion Control. Automation of Reports and Consolidated Orders System (ARCOS); 1996–2006: http://www.deadiversion.usdoj.gov/arcos/retrail_drug_summary/2006/06_rpt4.pdf (accessed July 26, 2012).en_US
dc.identifier.citedreferenceTrescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non‐cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. 2008; 11 ( 2 suppl ): S5 – S62.en_US
dc.identifier.citedreferenceWhite AG, Birnbaum HG, Mareva MN, et al. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005; 11: 469 – 479.en_US
dc.identifier.citedreferenceO'Connor PG, Samet JH. Substance abuse. J Gen Intern Med. 2002; 17: 334 – 340.en_US
dc.identifier.citedreferenceNational Center for Health Statistics. Medication Therapy in Ambulatory Medical Care: United State, 2003–04. Vital and Health Statistics, Series 13, number 63, December, 2006. http://www.cdc.gov/hcha/data/series/ar_13/ar13_163.pdf#page=26 (accessed July 26, 2012).en_US
dc.identifier.citedreferenceCouto JE, Romney MC, Leider HL, Sharma S, Goldfarb NI. High rates of inappropriate drug use in the chronic pain population. Popul Health Manag. 2009; 12: 185 – 190.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention (CDC). Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008. MMWR Morb Mortal Wkly Rep. 2010; 59: 705 – 709.en_US
dc.identifier.citedreferenceOlsen Y, Daumit GL, Ford GE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006; 7: 225 – 235.en_US
dc.identifier.citedreferenceElixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998; 36: 8 – 27.en_US
dc.identifier.citedreferenceCharlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008; 61: 1234 – 1240.en_US
dc.identifier.citedreferenceVon Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992; 45: 197 – 203.en_US
dc.identifier.citedreferenceEmptage NP, Strum R, Robinson RL. Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs. Psychiatr Serv. 2005; 56: 468 – 474.en_US
dc.identifier.citedreferenceBecker A, Held H, Redaelli M, et al. Low back pain in primary care: costs of care and prediction of future health care utilizations. Spine. 2010; 35: 1714 – 1720.en_US
dc.identifier.citedreferenceMcDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain. 2012; 13: 988 – 996.en_US
dc.identifier.citedreferenceReid MC, Engles‐Horton LL, Weber MAB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002; 17: 173 – 179.en_US
dc.identifier.citedreferenceSullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP study. Pain. 2010; 150: 332 – 339.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.